NCT02689284 2025-03-17Combination Margetuximab and Pembrolizumab for Advanced, Metastatic HER2(+) Gastric or Gastroesophageal Junction CancerMacroGenicsPhase 1/2 Completed95 enrolled 26 charts
NCT01148849 2025-02-26Safety Study of MGAH22 in HER2-positive CarcinomasMacroGenicsPhase 1 Completed66 enrolled